EOLS
NASDAQStockEvolus, Inc.
$4.91-0.01 (-0.10%)
52-Week Range
$4.13
$13.59
Key Stats
Market Cap
317.9M
P/E Ratio
—
Dividend Yield
—
Beta
1.01
Volume
690.7K
Avg Volume
1.8M
Performance
1M
+14.72%
3M
-31.23%
6M
-25.94%
YTD
-26.93%
1Y
-62.80%
3Y
-42.17%
5Y
-60.85%
Price Chart
ETF Exposure
EOLS is held by 50 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| XPH | State Street SPDR S&P Pharmaceuticals ETF | 0.77% |
| PILL | Direxion Daily Pharmaceutical & Medical Bull 3X ETF | 0.15% |
| IHE | iShares U.S. Pharmaceuticals ETF | 0.09% |
| IWC | iShares Micro-Cap ETF | 0.06% |
| GSSC | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | 0.06% |
| SBIO.L | Invesco NASDAQ Biotech UCITS ETF | 0.03% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.03% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.02% |
| IWO | iShares Russell 2000 Growth ETF | 0.02% |
| XWD1.F | Xtrackers MSCI World Swap UCITS ETF | 0.02% |
| XWD1.SG | Xtrackers MSCI World Swap UCITS ETF | 0.02% |
| XWEH.DE | Xtrackers MSCI World Swap UCITS ETF 4C EUR Hedged | 0.02% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.01% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.01% |
| IWM | iShares Russell 2000 ETF | 0.01% |
| XRS2.DE | Xtrackers Russell 2000 UCITS ETF 1C | 0.01% |
| XRSU.L | Xtrackers Russell 2000 UCITS ETF 1C | 0.01% |
| XSU.TO | iShares U.S. Small Cap Index ETF (CAD-Hedged) | 0.01% |
| SC0K.DE | Invesco Russell 2000 UCITS ETF | 0.01% |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 0.01% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.01% |
| VTWO | Vanguard Russell 2000 ETF | 0.01% |
| RSSL | Global X - Russell 2000 ETF | 0.01% |
| UWM | ProShares - Ultra Russell2000 | 0.01% |
| URTY | ProShares - UltraPro Russell2000 | 0.01% |
| VXF | Vanguard Extended Market ETF | 0.00% |
| VHT | Vanguard Health Care ETF | 0.00% |
| SMMD | iShares Russell 2500 ETF | 0.00% |
| HDG | ProShares - Hedge Replication ETF | 0.00% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| IWV | iShares Russell 3000 ETF | 0.00% |
| VCNS.TO | Vanguard Conservative ETF Portfolio | 0.00% |
| VEQT.TO | Vanguard All-Equity ETF Portfolio | 0.00% |
| VRIF.TO | Vanguard Retirement Income ETF Portfolio | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| VUN.TO | Vanguard U.S. Total Market Index ETF | 0.00% |
| VUS.TO | Vanguard U.S. Total Market Index ETF (CAD-hedged) | 0.00% |
| XEQT.TO | iShares Core Equity ETF Portfolio | 0.00% |
| XUU.TO | iShares Core S&P U.S. Total Market Index ETF | 0.00% |
About EOLS ETF Exposure
Evolus, Inc. (EOLS) is held by 50 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 317.9M, EOLS is a widely held institutional stock. The stock currently trades at $4.91. Investors can gain exposure to EOLS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold EOLS, sorted by portfolio weight.